Advertisement

Advertisement

JP:2395 Stock Latest News

SNBL to Shift Meeting Leadership to Board Chair in Governance Revamp

Company AnnouncementsSNBL to Shift Meeting Leadership to Board Chair in Governance Revamp

SNBL Revamps Top Management to Drive Long-Term Growth

PremiumCompany Announcements

SNBL Revamps Top Management to Drive Long-Term Growth

1d ago

SNBL Releases Q3 FY2026 Results Briefing and Business Update

PremiumCompany Announcements

SNBL Releases Q3 FY2026 Results Briefing and Business Update

3M ago

SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher

PremiumCompany Announcements

SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher

3M ago

Shin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan

3M ago

SNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue

PremiumCompany AnnouncementsSNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue

4M ago

Shin Nippon Biomedical Announces Interim Dividends

Company Announcements

Shin Nippon Biomedical Announces Interim Dividends

6M ago

Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025

Company Announcements

Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025

6M ago

Shin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits

6M ago

Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025

9M ago

Shin Nippon Biomedical Laboratories Announces Year-End Dividend

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Announces Year-End Dividend

11M ago

Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025

12M ago

Shin Nippon Biomedical Reports Revenue Growth Amid Profit Decline

PremiumCompany AnnouncementsShin Nippon Biomedical Reports Revenue Growth Amid Profit Decline

12M ago

Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment

Company Announcements

Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment

1y ago

SNBL and Tasso, Inc. Form Joint Venture to Distribute Blood Collection Device in Japan

Company Announcements

SNBL and Tasso, Inc. Form Joint Venture to Distribute Blood Collection Device in Japan

1y ago

SNBL’s SNLD to Present Nasal Levodopa Study at AAN 2025

PremiumCompany Announcements

SNBL’s SNLD to Present Nasal Levodopa Study at AAN 2025

1y ago

Shin Nippon Biomedical Laboratories Ups Earnings Forecast for FY 2025

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Ups Earnings Forecast for FY 2025

1y ago

Shin Nippon Biomedical Laboratories Reports Revenue Growth Amid Profit Challenges

PremiumCompany Announcements

Shin Nippon Biomedical Laboratories Reports Revenue Growth Amid Profit Challenges

1y ago

SNBL Partners with Mizuho Bank for Eco Finance

PremiumCompany Announcements

SNBL Partners with Mizuho Bank for Eco Finance

1y ago

Shin Nippon’s Dr. Nagata Awarded Bhutan’s Top Honor

PremiumCompany AnnouncementsShin Nippon’s Dr. Nagata Awarded Bhutan’s Top Honor

1y ago

SNBL’s Satsuma Pharma Achieves FDA Milestone

Company Announcements

SNBL’s Satsuma Pharma Achieves FDA Milestone

1y ago

Shin Nippon Biomedical Laboratories Focuses on Governance and Growth

Company Announcements

Shin Nippon Biomedical Laboratories Focuses on Governance and Growth

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >